ORGANIGRAM GLOBAL INC (OGI.CA) Fundamental Analysis & Valuation

TSX:OGI • CA68617J1003

Current stock price

1.89 CAD
+0.02 (+1.07%)
Last:

This OGI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. OGI.CA Profitability Analysis

1.1 Basic Checks

  • OGI had positive earnings in the past year.
  • OGI had a negative operating cash flow in the past year.
  • OGI had negative earnings in each of the past 5 years.
  • In the past 5 years OGI reported 4 times negative operating cash flow.
OGI.CA Yearly Net Income VS EBIT VS OCF VS FCFOGI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • With a decent Return On Assets value of 3.42%, OGI is doing good in the industry, outperforming 78.79% of the companies in the same industry.
  • With a decent Return On Equity value of 4.92%, OGI is doing good in the industry, outperforming 78.79% of the companies in the same industry.
Industry RankSector Rank
ROA 3.42%
ROE 4.92%
ROIC N/A
ROA(3y)-32.94%
ROA(5y)-24.98%
ROE(3y)-37.82%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
OGI.CA Yearly ROA, ROE, ROICOGI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin of OGI (6.49%) is better than 81.82% of its industry peers.
  • OGI has a Gross Margin of 8.13%. This is in the lower half of the industry: OGI underperforms 78.79% of its industry peers.
Industry RankSector Rank
OM N/A
PM (TTM) 6.49%
GM 8.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI.CA Yearly Profit, Operating, Gross MarginsOGI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. OGI.CA Health Analysis

2.1 Basic Checks

  • OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OGI has been increased compared to 1 year ago.
  • Compared to 5 years ago, OGI has more shares outstanding
  • OGI has a worse debt/assets ratio than last year.
OGI.CA Yearly Shares OutstandingOGI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
OGI.CA Yearly Total Debt VS Total AssetsOGI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -0.16, we must say that OGI is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.16, OGI is in line with its industry, outperforming 51.52% of the companies in the same industry.
  • A Debt/Equity ratio of 0.17 indicates that OGI is not too dependend on debt financing.
  • The Debt to Equity ratio of OGI (0.17) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z -0.16
ROIC/WACCN/A
WACC8.2%
OGI.CA Yearly LT Debt VS Equity VS FCFOGI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • OGI has a Current Ratio of 2.73. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.
  • OGI has a Current ratio of 2.73. This is in the better half of the industry: OGI outperforms 66.67% of its industry peers.
  • A Quick Ratio of 1.32 indicates that OGI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.32, OGI is in line with its industry, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.32
OGI.CA Yearly Current Assets VS Current LiabilitesOGI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. OGI.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 118.94% over the past year.
  • OGI shows a strong growth in Revenue. In the last year, the Revenue has grown by 68.55%.
  • Measured over the past years, OGI shows a very strong growth in Revenue. The Revenue has been growing by 24.46% on average per year.
EPS 1Y (TTM)118.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.31%
Revenue 1Y (TTM)68.55%
Revenue growth 3Y21.14%
Revenue growth 5Y24.46%
Sales Q2Q%48.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.72% on average over the next years. This is a very strong growth
  • OGI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.43% yearly.
EPS Next Y183.47%
EPS Next 2Y51.05%
EPS Next 3Y37.96%
EPS Next 5Y23.72%
Revenue Next Year22.24%
Revenue Next 2Y18.01%
Revenue Next 3Y12.01%
Revenue Next 5Y16.43%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OGI.CA Yearly Revenue VS EstimatesOGI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
OGI.CA Yearly EPS VS EstimatesOGI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. OGI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • OGI is valuated rather expensively with a Price/Earnings ratio of 18.90.
  • 78.79% of the companies in the same industry are more expensive than OGI, based on the Price/Earnings ratio.
  • OGI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.23.
  • Based on the Price/Forward Earnings ratio of 27.72, the valuation of OGI can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OGI indicates a somewhat cheap valuation: OGI is cheaper than 66.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, OGI is valued a bit more expensive.
Industry RankSector Rank
PE 18.9
Fwd PE 27.72
OGI.CA Price Earnings VS Forward Price EarningsOGI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI.CA Per share dataOGI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • OGI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as OGI's earnings are expected to grow with 37.96% in the coming years.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y51.05%
EPS Next 3Y37.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OGI.CA Dividend Analysis

5.1 Amount

  • OGI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OGI.CA Fundamentals: All Metrics, Ratios and Statistics

ORGANIGRAM GLOBAL INC

TSX:OGI (3/25/2026, 7:00:00 PM)

1.89

+0.02 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-10
Earnings (Next)05-11
Inst Owners9.06%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap257.68M
Revenue(TTM)279.99M
Net Income(TTM)18.17M
Analysts77.78
Price Target3.44 (82.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-513.86%
Min EPS beat(2)-2513.86%
Max EPS beat(2)1486.14%
EPS beat(4)2
Avg EPS beat(4)-68.73%
Min EPS beat(4)-2513.86%
Max EPS beat(4)1486.14%
EPS beat(8)3
Avg EPS beat(8)-105.21%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.72%
Min Revenue beat(2)-14%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)0.89%
Min Revenue beat(4)-14%
Max Revenue beat(4)8.56%
Revenue beat(8)5
Avg Revenue beat(8)-0.51%
Revenue beat(12)6
Avg Revenue beat(12)-2.26%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)1.51%
PT rev (3m)12.33%
EPS NQ rev (1m)-150%
EPS NQ rev (3m)23.08%
EPS NY rev (1m)1263.33%
EPS NY rev (3m)13233.3%
Revenue NQ rev (1m)-5.55%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)6.18%
Valuation
Industry RankSector Rank
PE 18.9
Fwd PE 27.72
P/S 0.92
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.1
EY5.29%
EPS(NY)0.07
Fwd EY3.61%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS2.05
BVpS2.71
TBVpS1.98
PEG (NY)0.1
PEG (5Y)N/A
Graham Number2.47
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 4.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 6.49%
GM 8.13%
FCFM N/A
ROA(3y)-32.94%
ROA(5y)-24.98%
ROE(3y)-37.82%
ROE(5y)-28.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.52%
Cap/Sales 6.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.32
Altman-Z -0.16
F-Score4
WACC8.2%
ROIC/WACCN/A
Cap/Depr(3y)85.08%
Cap/Depr(5y)98.16%
Cap/Sales(3y)9.58%
Cap/Sales(5y)15.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)118.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%169.31%
EPS Next Y183.47%
EPS Next 2Y51.05%
EPS Next 3Y37.96%
EPS Next 5Y23.72%
Revenue 1Y (TTM)68.55%
Revenue growth 3Y21.14%
Revenue growth 5Y24.46%
Sales Q2Q%48.7%
Revenue Next Year22.24%
Revenue Next 2Y18.01%
Revenue Next 3Y12.01%
Revenue Next 5Y16.43%
EBIT growth 1Y24.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year246.88%
EBIT Next 3Y67.83%
EBIT Next 5Y45.95%
FCF growth 1Y36.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.8%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANIGRAM GLOBAL INC / OGI.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORGANIGRAM GLOBAL INC?

ChartMill assigns a fundamental rating of 4 / 10 to OGI.CA.


Can you provide the valuation status for ORGANIGRAM GLOBAL INC?

ChartMill assigns a valuation rating of 4 / 10 to ORGANIGRAM GLOBAL INC (OGI.CA). This can be considered as Fairly Valued.


What is the profitability of OGI stock?

ORGANIGRAM GLOBAL INC (OGI.CA) has a profitability rating of 2 / 10.


What is the valuation of ORGANIGRAM GLOBAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ORGANIGRAM GLOBAL INC (OGI.CA) is 18.9 and the Price/Book (PB) ratio is 0.7.


Can you provide the expected EPS growth for OGI stock?

The Earnings per Share (EPS) of ORGANIGRAM GLOBAL INC (OGI.CA) is expected to grow by 183.47% in the next year.